Details for New Drug Application (NDA): 203693
✉ Email this page to a colleague
The generic ingredient in NITROGLYCERIN is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 203693
Tradename: | NITROGLYCERIN |
Applicant: | Actavis Labs Fl Inc |
Ingredient: | nitroglycerin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 203693
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 0.3MG | ||||
Approval Date: | Oct 16, 2017 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 0.4MG | ||||
Approval Date: | Oct 16, 2017 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 0.6MG | ||||
Approval Date: | Oct 16, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription